|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | T-cell-mediated cytotoxicity against autologous malignant melanoma: analysiswith interleukin 2-dependent T-cell cultures 显示文摘 | Knuth A Danowski B Oettgen HF Old LJ | 1984 | Proc Natl Acad Sci USA1984，81，： | 1 |
| 2 | Anti-B2-glycoprotein I:prevalence,clinical correlations,and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus显示文摘 | Danowski A Kickler T Petri M | 2006 | J Rheumatol2006，33，： | 1 |
| 3 | Identifying collaborative innovation networks显示文摘 | DANOWSKI JAMES A | 2010 | Proeedia Social and Behavioral Sciences2010，2，4： | 1 |
| 4 | Anti-beta2-glyeoprotein I: prevalence, clinical correlatations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus显示文摘 | Danowski A Kiekler TS Petri M | 2006 | J Rheumatol2006，33，9： | 1 |
| 5 | Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes 显示文摘 | DANOWSKI B A MANAKA-YOSHIDA K I SANGER J M | 1992 | Cel| Biology1992，118，： | 1 |
| 6 | Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus显示文摘 | DANOWSKI A DE AZEVEDO M N DE SOUZA PAPI J A | | 0，，06： | 1 |
| 7 | Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus 显示文摘 | Danowski A de Azevedo MN de Souza Papi JA | 2009 | J Rheumatol2009，36，6： | 1 |
| 8 | Determi- nants of risk for venous and arterial thrombosis in primary antiphos- pholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus 显示文摘 | Danowski A de Azevedo MN de Souza Papi JA | 2009 | J Rheumatol2009，36，6： | 1 |
| 9 | Guidelines for the treatment of antiphospholipid syndrome显示文摘 | DANOWSKI A REGO J KAKEHASI A M | 2013 | Revista Brasileira de Reumatologia2013，53，： | 1 |
| 10 | Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus显示文摘 | Danowski A de Azevedo MN de Souza Papi JA | 2009 | J Rheumatol2009，36，6： | 1 |
| 11 | Anti-beta2-glycoprotein I : prevalence,clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus显示文摘 | Danowski A Kiekler TS Petri M | 2006 | J Rheumatol2006，33，9： | 1 |
| 12 | Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and sys- temic lupus erythematosus显示文摘 | Danowski A Kickler TS Petri M | 2006 | J Rheumatol2006，33，9： | 1 |
| 13 | Anti-β2-glyeoprotein I : prev- alence, clinical correlations, and importance of persistent positiv- ity in patients with antiphospholipid syndrome and systemic lupus erythematosus 显示文摘 | Danowski A Kiekler TS Petri M | 2006 | J Rheumatol2006，33，9： | 1 |
| 14 | Anti-β2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus 显示文摘 | Danowski A Kickler TS Petri M | 2006 | J Rheumatol2006，33，9： | 1 |
| 15 | Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syn- drome with systemic lupus erythematosus 显示文摘 | Danowski A | 2009 | J Rheumatol2009，36，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员